Michael Owen, M.D., Ph.D.

Printer-friendly version
Michael Owen, M.D., Ph.D.

“We feel that by discovering the genes, we're priming this next stage of development, so we hope that in the future people will benefit through having new treatments.”

Dr. Owen is Deputy Director of the Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics and of the Institute of Psychological Medicine and Clinical Neurosciences at Cardiff University School of Medicine, in Wales, where he is also Professor of Psychiatric Genetics. The main focus of his research has been on the genetics of schizophrenia and on basic laboratory methods related to genomics and gene regulation. His landmark research with Michael O’Donovan, M.D., Ph.D., (who also won the Lieber Prize this year) involves the application of molecular genetic technology to identify specific risk genes for schizophrenia and optimize treatment decisions for individual patients.

"The genetics of schizophrenia has really been transformed over the past 5 years. 5 years ago we knew that the disorder was genetic, now we have a wealth of evidence telling us that disorders like schizophrenia, the genetic component is really complex..."

Dr. Owen was recognized for his research and his career of work at the Brain & Behavior Research Foundation 25th Anniversary National Awards Dinner in New York City in October, 2012 with the Lieber Prize for Schizophrenia Research.